Cargando…

Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials

The impact of agonist dose and of physician, staff and patient engagement on treatment have not been evaluated together in an analysis of treatment for opioid use disorder. Our hypotheses were that greater agonist dose and therapeutic engagement would be associated with reduced illicit opiate use in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergen, Andrew W., Baurley, James W., Ervin, Carolyn M., McMahan, Christopher S., Bible, Joe, Stafford, Randall S., Mudumbai, Seshadri C., Saxon, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998781/ https://www.ncbi.nlm.nih.gov/pubmed/35409790 http://dx.doi.org/10.3390/ijerph19074106

Ejemplares similares

Assessing Opioid Use Disorder Treatments in Trials Subject to Non-Adherence via a Functional Generalized Linear Mixed-Effects Model
por: St. Ville, Madeleine, et al.
Publicado: (2022)

Predicting nicotine metabolism across ancestries using genotypes
por: Baurley, James W., et al.
Publicado: (2022)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden
por: Richert, Torkel, et al.
Publicado: (2013)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
por: Winstanley, Erin L., et al.
Publicado: (2022)

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
por: Herring, Andrew A., et al.
Publicado: (2021)

Tailoring a brief intervention for illicit drug use and alcohol use in Irish methadone maintained opiate dependent patients: a qualitative process
por: Darker, Catherine, et al.
Publicado: (2016)

Sociodemographic and clinical characteristics of patients with long-term remission with buprenorphine / naloxone in opiate use disorder
por: Kahya, Y., et al.
Publicado: (2021)

Multiethnic Prediction of Nicotine Biomarkers and Association With Nicotine Dependence
por: Bergen, Andrew W, et al.
Publicado: (2021)

Adolescent prescription opioid misuse, illicit opioid use and overdose
por: Bohm, Michele K., et al.
Publicado: (2019)

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
por: Scott, Travis M., et al.
Publicado: (2017)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial
por: Wright, Nat MJ, et al.
Publicado: (2007)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Opioid peptides and opiate alkaloids in immunoregulatory processes
por: Stefano, George B., et al.
Publicado: (2010)

Historical Review: Opiate Addiction and Opioid Receptors
por: Wang, Shaocheng
Publicado: (2018)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment
por: Yee, Anne, et al.
Publicado: (2019)

Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain
por: Coffin, Phillip O., et al.
Publicado: (2020)

Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon
por: Ghaddar, Ali, et al.
Publicado: (2017)

Illicit Opioid Intoxication: Diagnosis and Treatment
por: Fareed, A., et al.
Publicado: (2011)

A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2012)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop
por: Simon, Alan E., et al.
Publicado: (2021)

Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females
por: Clarke, Toni-Kim, et al.
Publicado: (2013)

A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder
por: Seguí, Hemanuel Arroyo, et al.
Publicado: (2020)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
por: Weiner, Scott G., et al.
Publicado: (2023)

Modeling the Dynamics of Heroin and Illicit Opioid Use Disorder, Treatment, and Recovery
por: Cole, Sandra, et al.
Publicado: (2022)

Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department
por: Martin, Alister, et al.
Publicado: (2020)

Opioid Substitution Treatment Using Buprenorphine for Management of Dependence on Natural Opioids: Case Series
por: Kathiresan, Preethy, et al.
Publicado: (2019)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
por: Chambers, Laura C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_47c6m169fpcpc3g0d4qve4mct2